Literature DB >> 32696274

Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.

Xueshu Tao1, Michael S Lee1, Christopher R Donnelly1, Ru-Rong Ji2,3,4.   

Abstract

The current crises in opioid abuse and chronic pain call for the development of nonopioid and nonpharmacological therapeutics for pain relief. Neuromodulation-based approaches, such as spinal cord stimulation, dorsal root ganglion simulation, and nerve stimulation including vagus nerve stimulation, have shown efficacy in achieving pain control in preclinical and clinical studies. However, the mechanisms by which neuromodulation alleviates pain are not fully understood. Accumulating evidence suggests that neuromodulation regulates inflammation and neuroinflammation-a localized inflammation in peripheral nerves, dorsal root ganglia/trigeminal ganglia, and spinal cord/brain-through neuro-immune interactions. Specialized proresolving mediators (SPMs) such as resolvins, protectins, maresins, and lipoxins are lipid molecules produced during the resolution phase of inflammation and exhibit multiple beneficial effects in resolving inflammation in various animal models. Recent studies suggest that SPMs inhibit inflammatory pain, postoperative pain, neuropathic pain, and cancer pain in rodent models via immune, glial, and neuronal modulations. It is noteworthy that sham surgery is sufficient to elevate resolvin levels and may serve as a model of resolution. Interestingly, it has been shown that the vagus nerve produces SPMs and vagus nerve stimulation (VNS) induces SPM production in vitro. In this review, we discuss how neuromodulation such as VNS controls pain via immunomodulation and neuro-immune interactions and highlight possible involvement of SPMs. In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain. Furthermore, auricular stimulation is able to increase resolvin levels in mice. Thus, we propose that neuromodulation may control pain and inflammation/neuroinflammatioin via SPMs. Finally, we discuss key questions that remain unanswered in our understanding of how neuromodulation-based therapies provide short-term and long-term pain relief.

Entities:  

Keywords:  Auricular stimulation; chemotherapy; dorsal root ganglion; fish oil; resolvin; vagus nerve stimulation

Mesh:

Substances:

Year:  2020        PMID: 32696274      PMCID: PMC7609770          DOI: 10.1007/s13311-020-00892-9

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   6.088


  136 in total

1.  Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain.

Authors:  Jeffrey A M Coull; Dominic Boudreau; Karine Bachand; Steven A Prescott; Francine Nault; Attila Sík; Paul De Koninck; Yves De Koninck
Journal:  Nature       Date:  2003-08-21       Impact factor: 49.962

2.  Spinal sensory projection neuron responses to spinal cord stimulation are mediated by circuits beyond gate control.

Authors:  Tianhe C Zhang; John J Janik; Ryan V Peters; Gang Chen; Ru-Rong Ji; Warren M Grill
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

Review 3.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

4.  p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia.

Authors:  Ru-Rong Ji; Tarek A Samad; Shan-Xue Jin; Raymond Schmoll; Clifford J Woolf
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

5.  Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology.

Authors:  Isaac M Chiu; Christian A von Hehn; Clifford J Woolf
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

Review 6.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 7.  Spinal Circuits Transmitting Mechanical Pain and Itch.

Authors:  Bo Duan; Longzhen Cheng; Qiufu Ma
Journal:  Neurosci Bull       Date:  2017-05-08       Impact factor: 5.203

8.  Effect of Electroacupuncture on the NTS is modulated primarily by acupuncture point selection and stimulation frequency in normal rats.

Authors:  Jun-Fan Fang; Jun-Ying Du; Xiao-Mei Shao; Jian-Qiao Fang; Zhe Liu
Journal:  BMC Complement Altern Med       Date:  2017-03-31       Impact factor: 3.659

9.  Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain.

Authors:  Jie Gao; Chaoliang Tang; Lydia Wai Tai; Yeling Ouyang; Na Li; Zhiqiang Hu; Xiangdong Chen
Journal:  J Pain Res       Date:  2018-08-10       Impact factor: 3.133

10.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.

Authors:  Makoto Arita; Francesca Bianchini; Julio Aliberti; Alan Sher; Nan Chiang; Song Hong; Rong Yang; Nicos A Petasis; Charles N Serhan
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  11 in total

Review 1.  A functional subdivision within the somatosensory system and its implications for pain research.

Authors:  Qiufu Ma
Journal:  Neuron       Date:  2022-01-10       Impact factor: 17.173

2.  Human leukocytes selectively convert 4S,5S-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer.

Authors:  Ashley E Shay; Robert Nshimiyimana; Bengt Samuelsson; Nicos A Petasis; Jesper Z Haeggström; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

Review 3.  Specialized pro-resolving lipid mediators in endodontics: a narrative review.

Authors:  Davy Aubeux; Ove A Peters; Sepanta Hosseinpour; Solène Tessier; Valérie Geoffroy; Fabienne Pérez; Alexis Gaudin
Journal:  BMC Oral Health       Date:  2021-05-24       Impact factor: 2.757

4.  Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; Ronald W Wood; Mitchell A Linder; Adrienne D Bonham; Kenneth V Honn; Krishna Rao Maddipati; Richard P Phipps; Constantine G Haidaris; David C Foster
Journal:  J Pain       Date:  2021-04-01       Impact factor: 5.383

5.  Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies.

Authors:  Christine N Sang; William K Schmidt
Journal:  Neurotherapeutics       Date:  2020-10-14       Impact factor: 6.088

Review 6.  Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.

Authors:  Christopher R Donnelly; Amanda S Andriessen; Gang Chen; Kaiyuan Wang; Changyu Jiang; William Maixner; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

7.  A new synthetic protectin D1 analog 3-oxa-PD1n-3 DPA reduces neuropathic pain and chronic itch in mice.

Authors:  Jannicke Irina Nesman; Ouyang Chen; Xin Luo; Ru-Rong Ji; Charles N Serhan; Trond Vidar Hansen
Journal:  Org Biomol Chem       Date:  2021-03-09       Impact factor: 3.876

8.  Spinal Cord Stimulation Attenuates Mechanical Allodynia and Increases Central Resolvin D1 Levels in Rats With Spared Nerve Injury.

Authors:  Xueshu Tao; Xin Luo; Tianhe Zhang; Brad Hershey; Rosana Esteller; Ru-Rong Ji
Journal:  Front Physiol       Date:  2021-06-25       Impact factor: 4.566

9.  Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol.

Authors:  Eric Azabou; Guillaume Bao; Félicie Costantino; Madalina Jacota; Chanez Lazizi; Lionelle Nkam; Martin Rottman; Anne-Laure Roux; Sylvain Chevallier; Lamiae Grimaldi; Maxime Breban
Journal:  Front Hum Neurosci       Date:  2021-06-30       Impact factor: 3.169

10.  N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Pauline Bottemanne; Owein Guillemot-Legris; Adrien Paquot; Julien Masquelier; Michael Malamas; Alexandros Makriyannis; Mireille Alhouayek; Giulio G Muccioli
Journal:  Neurotherapeutics       Date:  2021-07-07       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.